Companion Society Meetings

Association for Molecular Pathology

Disruptive Technologies in Surgical and Molecular Pathology

Sunday, March 18, 2018, 7:30 - 10:30 PM

Session Credits:

3 CME and 3 SAMs

Moderators:

Cecilia CS Yeung, MD, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA
Yaolin Zhou, MD, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Course Description:

Molecular pathology plays a central role in the diagnosis, classification, and prognostication and increasingly plays a role in the selection of treatment modalities. Keeping up with the relentless expansion of technological innovations into our trade creates practical challenges for surgical pathologists and laboratories alike. Furthermore, these disruptive technologies may revolutionize the way we care for patients. By definition however, their implementation can create new problems and adaptations of these disruptive technologies can be difficult.

In this session we will address the impact of these disruptive technologies:

  • What is new in telepathology and digital pathology? Where does molecular testing interface?
  • What are approaches to validating clinical assays for immunotherapy in molecular laboratories?
  • How can liquid biopsies help with the management of oncology patients? What is the role of the pathologist?

Each speaker will address a specific challenge by presenting a short lecture. We will conclude with a panel discussion with the presenting speakers sharing challenges from their institutions as they relate to regulatory issues, validation, and reimbursement. The audience will be invited to share their challenges and solutions during these discussions.

 

7:30 PM Introduction
Cecilia CS Yeung, MD, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA
7:40 PM Image Analysis and Biomarker Evaluation: Linking Digital Pathology and Molecular Diagnostics
Andrew J. Evans, MD, PhD, FRCPC, University Health Network, University of Toronto, Toronto, ON, Canada
8:10 PM High-Throughput Cancer Genomics as a Disruptive Technology
Fei Dong, MD, Brigham and Women's Hospital, Boston, MA
8:40 PM Synergism Between Liquid Biopsy Testing and Pathology in Oncology Patients
Christina Lockwood, PhD, DABCC, DABMGG, University of Washington, Seattle, WA
9:10 PM Summary
Yaolin Zhou, MD, University of Oklahoma Health Sciences Center, Oklahoma City, OK
9:15 PM Group Discussion

 

Continuing Medical Education and Maintenance of Certification

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and Association of Molecular Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of
3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 3 SAM credit hours.

 

Return to 2018 Annual Meeting Companion Society Meetings Page

Meetings

view more